Stress and thyroid autoimmunity

Thyroid

Volumn 14, Issue 12, 2004, Pages 1047-1055

  Mizokami, Tetsuya ^a   Li, Audrey Wu ^b   El Kaissi, Samer ^a   Wall, Jack R ^a,c  

^a GEELONG HOSPITAL   (Australia)

^b DALHOUSIE UNIVERSITY   (Canada)

^c UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR; GLUCOCORTICOID; NORADRENALIN; PROTIRELIN; SEX HORMONE;

AUTOIMMUNITY; DISEASE COURSE; DISEASE PREDISPOSITION; DRUG INHIBITION; ENVIRONMENTAL FACTOR; GRAVES DISEASE; HASHIMOTO DISEASE; HUMAN; IMMUNE RESPONSE; IMMUNOMODULATION; IMMUNOSUPPRESSIVE TREATMENT; NERVE CONDUCTION; NONHUMAN; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE ACTIVATION; THYROID DISEASE;

ANIMALS; DISEASE PROGRESSION; GRAVES DISEASE; HUMANS; NEUROSECRETORY SYSTEMS; STRESS; THYROIDITIS, AUTOIMMUNE;

EID: 11344286242     PISSN: 10507256     EISSN: None     Source Type: Journal    
DOI: 10.1089/thy.2004.14.1047     Document Type: Review

References (75)

1. Pacák K, Palkovits M 2001 Stressor specificity of central neuroendocrine responses: Implications for stress-related disorders. Endocr Rev 22:502-548.
2. Wilder RL 1995 Neuroendocrine-immune system interactions and autoimmunity. Ann Rev Immunol 13:307-338.
3. Chrousos GP 1998 Stressors, stress, and neuroendocrine integration of the adaptive response. The 1997 Hans Selye memorial lecture. Ann NY Acad Sci 851:311-335.
4. Cohen S, Herbert TB 1996 Health psychology: Psychological factors and physical disease from the perspective of human psychoneuroimmunology. Ann Rev Psychol 47:113-142.
5. Chrousos GP, Gold PW 1992 The concepts of stress and stress system disorders. Overview of physical and behavioral homeostasis. JAMA 267: 1244-1252.
6. Leclère J, Weryha G 1989 Stress and auto-immune endocrine diseases. Horm Res 31:90-93.
7. Rogers MP, Fozdar M 1996 Psychoneuroimmunology of autoimmune disorders. Adv Neuroimmunol 6:169-177.
8. Walker JG, Littlejohn GO, McMurray NE, Cutolo M 1999 Stress system response and rheumatoid arthritis: A multilevel approach. Rheumatology (Oxf) 38:1050-1057.
9. Jedryka-Goral A, Maslinski W, Ziolkowska M, Konarska M, Zolnierczyk-Zreda D 2002 Stress - Where are we now? Does immunity play an intrinsic role? Autoimmunity 35:421-426.
10. Rosch PJ 1993 Stressful life events and Graves' disease. Lancet 342:566-567.
11. Chiovato L, Pinchera A 1996 Stressful life events and Graves' disease. Eur J Endocrinol 134:680-682.
12. Dayan CM 2001 Stressful life events and Graves' disease revisited. Clin Endocrinol (Oxf) 55:13-14.
13. Winsa B, Adami H, Bergström R, Gamstedt A, Dahlberg PA, Adamson U, Jansson R, Karlsson A 1991 Stressful life events and Graves' disease. Lancet 338:1475-1479.
14. Sonino N, Girelli ME, Boscaro M, Fallo F, Busnardo B, Fava GA 1993 Life events in the pathogenesis of Graves' disease. A controlled study. Acta Endocrinol (Copenh) 128:293-296.
15. Kung AW 1995 Life events, daily stresses and coping in patients with Graves' disease. Clin Endocrinol (Oxf) 42:303-308.
16. Radosavljević VR, Janković SM, Marinković JM 1996 Stressful life events in the pathogenesis of Graves' disease. Eur J Endocrinol 134:699-701.
17. Yoshiuchi K, Kumano H, Nomura S, Yoshimura H, Ito K, Kanaji Y, Ohashi Y, Kuboki T, Suematsu H 1998 Stressful life events and smoking were associated with Graves' disease in women, but not in men. Psychosom Med 60:182-185.
18. Matos-Santos A, Nobre EL, Costa JGE, Nogueira PJ, Macedo A, Galvao-Teles A, de Castro JJ 2001 Relationship between the number and impact of stressful life events and the onset of Graves' disease and toxic nodular goitre. Clin Endocrinol (Oxf) 55:15-19.
19. Stewart T, Rochon J, Lenfestey R, Wise P 1985 Correlation of stress with outcome of radioiodine therapy for Graves' disease. J Nucl Med 26:592-599.
20. Benvenga S 1996 Benzodiazepine and remission of Graves' disease. Thyroid 6:659-660.
21. Yoshiuchi K, Kumano H, Nomura S, Yoshimura H, Ito K, Kanaji Y, Kuboki T, Suematsu H 1998 Psychosocial factors influencing the short-term outcome of antithyroid drug therapy in Graves' disease. Psychosom Med 60:592-596.
22. Fukao A, Takamatsu J, Murakami Y, Sakane S, Miyauchi A, Kuma K, Hayashi S, Hanafusa T 2003 The relationship of psychological factors to the prognosis of hyperthyroidism in antithyroid drug-treated patients with Graves' disease. Clin Endocrinol (Oxf) 58:550-555.
23. Paunkovic N, Paunkovic J, Pavlovic O, Paunovic Z 1998 The significant increase in incidence of Graves' disease in eastern Serbia during the civil war in the former Yugoslavia (1992 to 1995). Thyroid 8:37-41.
24. Hadden DR, McDevitt EDG 1974 Environmental stress and thyrotoxicosis. Absence of association. Lancet 2:577-578.
25. Chiovato L, Barbesino G, Pinchera A 2000 Graves' disease. In: DeGroot LJ, Jameson JL (eds) Endocrinology, 4th ed. WB Saunders Company, Philadelphia, 2001, pp. 1422-1449.
26. Matsubayashi S, Tamai H, Matsumoto Y, Tamagawa K, Mukuta T, Morita T, Kubo C 1996 Graves'disease after the onset of panic disorder. Psychother Psychosom 65:277-280.
27. Chiovato L, Marinò M, Perugi G, Fiore E, Montanelli L, Lapi P, Cavaliere R, Ciampi M, Patronelli A, Placidi G, Placidi GF, Cassano GB, Pinchera A 1998 Chronic recurrent stress due to panic disorder does not precipitate Graves' disease. J Endocrinol Invest 21:758-764.
28. Misaki T, Iwata M, Kasagi K, Iida Y, Akamizu T, Kosugi S, Konishi J 2000 Hyperthyroid Graves' disease after hemithyroidectomy for papillary carcinoma: Report of three cases. Endocr J 47:191-195.
29. Morillo E, Gardner LI 1979 Bereavement as an antecedent factor in thyrotoxicosis of childhood: Four case studies with survey of possible metabolic pathways. Psychosom Med 41:545-555.
30. Morillo E, Gardner LI 1980 Activation of latent Graves' disease in children. Review of possible psychosomatic mechanisms. Clin Pediatr (Phila) 19:160-163.
31. Gray J, Hoffenberg R 1985 Thyrotoxicosis and stress. Q J Med 54:153-160.
32. Simon NM, Safren SA, Otto MW, Sharma SG, Lanka GD, Pollack MH 2002 Longitudinal outcome with pharmacotherapy in a naturalistic study of panic disorder. J Affect Disord 69:201-208.
33. Martin-du Pan RC 1998 Triggering role of stress and pregnancy in the occurrence of 98 cases of Graves' disease compared to 95 cases of Hashimoto thyroiditis and 97 cases of thyroid nodules. Ann Endocrinol (Paris) 59:107-112.
34. Harris T, Creed F, Brugha TS 1992 Stressful life events and Graves' disease. Br J Psychiatry 161:535-541.
35. Ben-Shlomo Y, Chaturvedi N 1992 Stress and Graves' disease. Lancet 339:427.
36. Petticrew M 1992 Stress and Graves' disease. Lancet 339:427.
37. Stern RA, Robinson B, Thorner AR, Arruda JE, Prohaska ML, Prange AJ Jr 1996 A survey study of neuropsychiatric complaints in patients with Graves' disease. J Neuropsychiatry Clin Neurosci 8:181-185.
38. Oretti RG, Harris B, Lazarus JH, Parkes AB, Crownshaw T 2003 Is there an association between life events, postnatal depression and thyroid dysfunction in thyroid antibody positive women? Int J Soc Psychiatry 49:70-76.
39. Carter WR, Herrman J, Stokes K, Cox DJ 1987 Promotion of diabetes onset by stress in the BB rat. Diabetologia 30:674-675.
40. Durant S, Coulaud J, Amrani A, el Hasnaoui A, Dardenne M, Homo-Delarche F 1993 Effects of various environmental stress paradigms and adrenalectomy on the expression of autoimmune type 1 diabetes in the non-obese diabetic (NOD) mouse. J Autoimmunol 6:735-751.
41. Lehman CD, Rodin J, McEwen B, Brinton R 1991 Impact of environmental stress on the expression of insulin-dependent diabetes mellitus. Behav Neurosci 105:241-245.
42. Habib KE, Gold PW, Chrousos GP 2001 Neuroendocrinology of stress. Endocrinol Metab Clin North Am 30:695-728.
43. Chrousos GP, Torpy DJ, Gold PW 1998 Interactions between the hypothalamic-pituitary-adrenal axis and the female reproductive system: Clinical implications. Ann Intern Med 129:229-240.
44. Ferin M 1999 Stress and the reproductive cycle. J Clin Endocrinol Metab 84:1768-1774.
45. Sternberg EM 2001 Neuroendocrine regulation of autoimmune/inflammatory disease. J Endocrinol 169:429-435.
46. Sapolsky RM, Romero LM, Munck AU 2000 How do glucocorticoids influence stress responses? Integrating permissive, suppressive, stimulatory, and preparative actions. Endocr Rev 21:55-89.
47. Elenkov IJ, Chrousos GP 1999 Stress, cytokine patterns and susceptibility to disease. Baillière's Clin Endocrinol Metab 13:583-595.
48. Elenkov IJ, Wilder RL, Chrousos GP, Vizi ES 2000 The sympathetic nerve - An integrative interface between two supersystems: The brain and the immune system. Pharmacol Rev 52:595-638.
49. Green PG, Miao FJ, Strausbaugh H, Heller P, Janig W, Levine JD 1998 Endocrine and vagal controls of sympathetically dependent neurogenic inflammation. Ann NY Acad Sci 840:282-288.
50. Rivier C, Rivest S 1991 Effect of stress on the activity of the hypothalamic-pituitary-gonadal axis: Peripheral and central mechanisms. Biol Reprod 45:523-532.
51. Da Silva JAP 1999 Sex hormones and glucocorticoids: Interactions with the immune system. Ann NY Acad Sci 876:102-117.
52. Ahmed SA, Hissong BD, Verthelyi D, Donner K, Becker K, Karpuzoglu-Sahin E 1999 Gender and risk of autoimmune diseases: Possible role of estrogenic compounds. Environ Health Perspect 107(Suppl 5):681-686.
53. Olsen NJ, Kovacs WJ 1996 Gonadal steroids and immunity. Endocr Rev 17:369-384.
54. Cremaschi GA, Gorelik G, Klecha AJ, Lysionek AE, Genaro AM 2000 Chronic stress influences the immune system through the thyroid axis. Life Sci 67:3171-3179.
55. th ed. Lippincott Williams & Wilkins, Philadelphia, pp. 642-651.
56. Dluby RG 2000 The adrenal cortex in thyrotoxicosis. In: Braverman LE, Utiger RD (Eds), Werner and Ingbar's The Thyroid: 8th ed. Lippincott Williams & Wilkins, Philadelphia, pp. 637-641.
57. Kamilaris TC, DeBold CR, Johnson EO, Mamalaki E, Listwak SJ, Calogero AE, Kalogeras KT, Gold PW, Orth DN 1991 Effects of short and long duration hypothyroidism and hyperthyroidism on the plasma adreno corticotropin and corticosterone responses to ovine corticotropin-releasing hormone in rats. Endocrinology 128:2567-2576.
58. Silberman DM, Wald M, Genaro AM 2002 Effects of chronic mild stress on lymphocyte proliferative response. Participation of serum thyroid hormones and corticosterone. Int Immunopharmacol 2:487-497.
59. Dorshkind K, Horseman ND 2000 The roles of prolactin, growth hormone, insulin-like growth factor-I, and thyroid hormones in lymphocyte development and function: Insights from genetic models of hormone and hormone receptor deficiency. Endocr Rev 21:292-312.
60. Biondi M, Picardi A 1999 Psychological stress and neuroendocrine function in humans: The last two decades of research. Psychother Psychosom 68:114-150.
61. Herbert TB, Cohen S 1993 Stress and immunity in humans: A meta-analytic review. Psychosom Med 55:364-379.
62. Cohen S, Miller GE, Rabin BS 2001 Psychological stress and antibody response to immunization: A critical review of the human literature. Psychosom Med 63:17-18.
63. Ligier S, Sternberg EM 1999 Neuroendocrine host factors and inflammatory disease susceptibility. Environ Health Perspect 107(Suppl 5):701-707.
64. Wick G, Hu Y, Schwarz S, Kroemer G 1993 Immunoendocrine communication via the hypothalamo-pituitary-adrenal axis in autoimmune diseases. Endocr Rev 14:539-563.
65. Hu Y, Dietrich H, Herold M, Heinrich PC, Wick G 1993 Disturbed immuno-endocrine communication via the hypothalamo-pituitary-adrenal axis in autoimmune disease. Int Arch Allergy Immunol 102:232-241.
66. Tomer Y, Davies TF 2003 Searching for the autoimmune thyroid disease susceptibility genes: From gene mapping to gene function. Endocr Rev 24:694-717.
67. Volpé R 1991 Graves' disease: pathogenesis. In: Braverman LE, Utiger RD (eds) Werner and Ingbar's The Thyroid: A Clinical and Fundamental Text, 6th ed. Lippincott Williams & Wilkins, Philadelphia, pp. 648.
68. DeGroot LJ 1996 Graves' disease and the manifestation of thyrotoxicosis. In: DeGroot LJ, Larsen PR, Hennemann G (eds) The Thyroid and its Diseases. Churchill Livingstone, New York, pp. 371.
69. Amino N, Hidaka Y, Takano T, Izumi Y, Tatsumi K, Nakata Y 2003 Association of seasonal allergic rhinitis is high in Graves' disease and low in painless thyroiditis. Thyroid 13:811-814.
70. Coles AJ, Wing M, Smith S, Coraddu F, Greer S, Taylor C, Weetman A, Hale G, Chatterjee VK, Waldmann H, Compston A 1999 Pulsed monoclonal antibody treatment and autoimmune thyroid disease in multiple sclerosis. Lancet 354:1691-1965.
71. Nagayama Y, Mizuguchi H, Hayakawa T, Niwa M, McLachlan SM, Rapoport B 2003 Prevention of autoantibody-mediated Graves'-like hyperthyroidism in mice with IL-4, a Th2 cytokine. J Immunol 170:3522-3527.
72. Davies TF 2000 Graves' disease: pathogenesis. In: Braverman LE, Utiger RD (eds) Werner and Ingbar's The Thyroid, The Clinical and Fundamental Text, 8th ed. Lippincott Williams & Wilkins, Philadelphia, pp. 518.
73. Amino N, Tada H, Hidaka Y, Izumi Y 2000 Postpartum autoimmune thyroid syndrome. Endocr J 47:645-655.
74. Arbuckle MR, McClain MT, Rubertone MV, Scofield RH, Dennis GJ, James JA, Harley JB 2003 Development of autoantibodies before the clinical onset of systemic lupus erythematosus. N Engl J Med 349:1526-1533.
75. Batstra MR, Aanstoot HJ, Herbrink P 2001 Prediction and diagnosis of type 1 diabetes using beta-cell autoantibodies. Clin Lab 47:497-507.